The transmembrane glycoprotein CD98 regulates integrin signaling that in turn controls cell proliferation and survival. CD98 expression is upregulated in various carcinomas, including colorectal cancer. Recently, by generating gain-and loss-of-function mouse models featuring genetic manipulation of CD98 expression specifically in intestinal epithelial cells (IECs), we have explored the crucial role of CD98 in the regulation of intestinal homeostasis and inflammation-associated tumorigenesis. In the present study, we investigated the contribution of CD98 to intestinal tumorigenesis in Apc Min/ þ mice and the underlying mechanism of action. Mice featuring IEC-specific CD98 overexpression (Tg animals) were crossed with Apc
The transmembrane glycoprotein CD98 associates with integrin b 1 subunits, thereby regulating integrin signaling that in turn controls cell proliferation, survival, migration, and epithelial adhesion/polarity. [1] [2] [3] Expression of the transmembrane glycoprotein CD98, encoded by SLC3A2, is increased in various carcinomas. [4] [5] [6] [7] Recently, we generated both gain-and loss-of-function mouse models featuring genetic manipulation of CD98 expression specifically in intestinal epithelial cells (IECs), and explored the roles of CD98 in intestinal homeostasis, inflammation, and colitis-associated tumorigenesis. 8 The adenomatous polyposis coli (APC) gene is critical for initiation of colorectal cancer (CRC), one of the most common malignancies worldwide. 9 APC is mutated in 495% of familial adenomatous polyposis patients, and in 80% of those with sporadic CRC. 10 The Apc Min/ þ mouse, which contains a germline mutation in APC, serves as an animal model of human familial adenomatous polyposis. 11 Apc
Min/ þ mice spontaneously develop numerous adenomas in the small intestine. 12 APC is involved in the action of the Wnt-bcatenin signaling pathway and, importantly, regulates proliferation of intestinal crypt epithelia. In the absence of Wnt signaling, APC permits phosphorylation of b-catenin, leading to ubiquitination and degradation of the latter protein. 13 In the early stages of intestinal tumorigenesis, mutational inactivation of APC both stabilizes and facilitates nuclear accumulation of b-catenin. 14 In the nucleus, b-catenin forms a complex with T-cell factor (TCF); this complex in turn activates oncogenes including c-myc 15 and cyclin D1. 16, 17 In the present study, we used two genetically manipulated mouse strains 8 that exhibit either IEC-specific CD98 overexpression or downregulation. We investigated the role shown by CD98, and its mechanism(s) of action, in intestinal tumorigenesis in Apc Min/ þ mice.
MATERIALS AND METHODS
Mice CD98 transgenic (Tg) and CD98 f/ þ VillinCre (CD98 f/ þ VC) mice were previously generated. 8 Founder C57BL/6J male mice heterozygous for the Apc Min allele (Apc Min/ þ ) were purchased from the Jackson Laboratory. Tg mice were congenically rebred to C57Bl/6 (Jackson Laboratories) for eight generations. Tg females were mated with Apc Min/ þ males to generate wild-type (WT), Tg, Apc
Min/ þ , and Tg/Apc
Min/ þ mice. CD98 f/ þ VC females were mated with Apc Min/ þ males to generate CD98 f/ þ , CD98 f/ þ VC, CD98 f/ þ /Apc Min/ þ , and CD98 f/ þ VC/Apc Min/ þ mice. Mice were maintained in standard cages and were allowed standard chow and tap water ad libitum. All animal procedures were in accordance with the Emory University Institutional Animal Care and Use Committee.
Tumor Assessment
Mice were sacrificed at 16 weeks of age by CO 2 asphyxiation. The entire small intestine and colon were dissected longitudinally. Intestinal tissues were examined under a dissecting microscope in a blinded fashion for the presence of adenomas. Intestinal adenomas were counted and grouped by size as follows: o1, 1-2, 2-3, and 43 mm.
Histology
Tissue sections were fixed in 10% formalin and embedded in paraffin. Sections of 5 mm were stained with H&E. Photomicrographs were taken using a Nikon Eclipse TS100 microscope.
Immunohistochemistry
Paraffin-embedded colonic sections of 5 mm were deparaffinized and antigen unmasking was performed by microwave treatment. Colonic sections were blocked in PBS with 10% normal goat serum for 30 min at 371C, and then incubated with anti-Ki67 (Novocastra), anti-b-catenin (BD Biosciences) overnight at 41C. After washes with PBS, tissues were treated with biotinylated secondary antibody (Vectastain Elite ABC kit, Vector Laboratories) for 1 h at room temperature. Sections were washed with PBS, incubated in the ABC reagent for 1 h at room temperature, washed again, and incubated with a peroxidase solution (Aminoethyl Carbazole Substrate Kit, Zymed). Sections were then counterstained with hematoxylin, dehydrated, and mounted in ProLong Gold (Invitrogen). Images were acquired using a Zeiss Axioskop 2 plus microscope equipped with an AxioCam MRc5 CCD camera (Zeiss).
TUNEL (Terminal Deoxynucleotidyl TransferaseMediated Deoxyuridine Triphosphate Nick-End Labeling) Assay Tissue sections were deparaffinized, and apoptotic cells were detected by immunofluorescent TUNEL using the In Situ Cell Death Detection Kit (Roche Applied Science). Nuclei were stained with 4 0 ,6-diamidino-2-phenylindole (Invitrogen). Sections were mounted and photographed as described above.
Intestinal Epithelial Cell Isolation
Isolation of epithelial cells from jejunum or colon was performed as previously described. 18, 19 Treatment of Caco2-BBE Cells with Lithium Chloride The human intestinal epithelial Caco2-BBE cells were cultured as described previously. 19, 20 Cells were serum starved overnight, and then treated with the canonical Wnt activator LiCl at 10 or 100 mM for 24 h. Untreated cells were used as controls. Cells were then washed, and the effect of LiClmediated Wnt pathway activation on levels of human CD98 or b-catenin (used as a positive control) was analyzed by western blot.
Western Blot
Cell lysates were resolved on polyacrylamide gels and transferred to nitrocellulose membranes (Bio-Rad). Membranes were probed with relevant primary antibodies followed by incubation with appropriate HRP-conjugated secondary antibodies (Amersham Biosciences). Blots were detected using the Enhanced Chemiluminescence Detection kit (Amersham Biosciences).
Quantitative Real-Time PCR (qRT-PCR) Total RNA extracted using TRIzol (Invitrogen) was reverse transcribed using the first strand cDNA synthesis kit (Fermentas). [4] [5] [6] [7] In the present report, we investigated whether CD98 expression was increased in intestinal adenomas developed in the wellestablished Apc
Min/ þ mouse model of intestinal tumorigenesis. Figure 1 shows that the levels of CD98 mRNA and protein expression increased in intestinal adenomas of Apc Min/ þ mice compared with those in normal intestinal tissue of Apc Min/ þ animals or intestinal epithelia of WT mice. No significant difference was found when CD98 expression levels in IECs derived from WT mice and non-tumor regions of Apc Min/ þ animals were compared ( Figure 1 ). This suggests that CD98 overexpression is specifically associated with intestinal tumorigenesis in Apc Min/ þ mice. As CD98 expression was upregulated in Apc
Min/ þ tumors, we tested the possibility that CD98 might function as a downstream target of Wnt/b-catenin pathway. For that, intestinal epithelial Caco2-BBE cells were treated with LiCl, which has been used as an activator of canonical Wnt signaling by acting through glycogen synthase kinase-3 beta inhibition. 21, 22 As expected, LiCl treatment induced a stabilization and accumulation of b-catenin in Caco2-BBE cells at both 10 and 100 mM, indicating activation of Wnt pathway (Supplementary Figure S1) . However, expression levels of human (h) CD98 in Caco2-BBE cells remained unchanged upon LiCl treatment, even at 100 mM (Supplementary Figure  S1 ). These data indicate that CD98 is not a direct downstream target of Wnt/b-catenin pathway. (Figure 2a) . In an effort to analyze the total expression levels of human (h) CD98 and endogenous murine (m) CD98 in Apc Min/ þ and Tg/Apc Min/ þ mice, we performed western blot analysis using an antibody that recognizes both hCD98 and mCD98. Our data showed a marked increase in total CD98 protein expression, including hCD98 and mCD98, in intestinal lysates from Tg/Apc 
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Min/ þ mice HTT Nguyen et al Histologically, the adenomas were consistently larger in small intestinal and colonic sections from Tg/Apc Min/ þ mice compared with Apc Min/ þ animals ( Figure 2g ). These findings indicated that CD98 expression in IECs regulates tumor development and progression in Apc Min/ þ mice.
IEC-Specific CD98 Overexpression Increases Cell Proliferation and Reduces Apoptosis in Apc
Min/ þ Mice We recently showed that IEC-specific CD98 overexpression affects integrin signaling, leading to changes in cell proliferation and survival. 8 As both cell proliferation and survival contribute to tumor growth, we investigated these properties in Tg/Apc Min/ þ mice in comparison with Apc
Min/ þ animals to understand the mechanism underlying the effect of IEC-specific CD98 overexpression on tumor development. Immunohistological staining for Ki67 revealed a significant increase in the number of Ki67-positive epithelia in Tg/ Apc Min/ þ mice compared with Apc Min/ þ animals, in both tumor and non-tumor regions (Figure 3a) . Consistent with this result, we found a significant increase in cyclin D1 mRNA and protein levels in intestinal lysates from Tg/Apc
Min/ þ mice compared with Apc Min/ þ animals (Figure 3b and c) . Furthermore, expression levels of cyclin D1 were increased in Tg/Apc Min/ þ compared with Apc Min/ þ mice in both adenomas and normal epithelia (Figure 3d ). In addition, Tg/Apc Min/ þ mice exhibited decreased apoptosis of the intestinal epithelium, as revealed by lower TUNEL-positive cell numbers (Figure 4a) , and increased phospho-Akt with reduced cleaved caspase 3 levels (Figure 4b) . Thus, IEC-specific CD98 overexpression enhances tumor development in Apc Min/ þ mice by promoting proliferation and decreasing apoptosis of IECs.
IEC-specific CD98 Overexpression Enhances Intestinal Tumorigenesis in Apc
Min/ þ Mice by Activating the MEK/ ERK Signaling Pathway Transcription of c-myc is induced by activation of b-catenin, which is mediated by APC inactivation. As c-myc is known to It is known that the MEK-ERK pathway phosphorylates c-myc, thereby stabilizing c-myc by preventing it from ubiquitination and proteasomal degradation. [23] [24] [25] It has recently been shown that ERK activation increases the level of c-myc protein and drives intestinal tumorigenesis in Apc Min/ þ mice. 26 We recently showed that IEC-specific CD98 overexpression increases activation of MEK-ERK signaling pathway. 8 Therefore, we examined the levels of phospho-ERK in Apc Min/ þ and Tg/Apc Min/ þ mice. Figure 5d shows that, compared with Apc Min/ þ mice, intestinal lysates of Tg/Apc Min/ þ animals exhibited a marked increase in phospho-ERK level. Together, these data suggested that IEC-specific CD98 overexpression promotes tumorigenesis in the Apc
Min/ þ mouse model by activating the MEK-ERK signaling pathway, independently of the Wnt-APC-b-catenin pathway.
However, we can not exclude the possibility that changes in phospho-ERK levels only reflect the changes in cycling cells in Tg/Apc Min/ þ animals, and the cause-consequence relationships between tumorigenesis and ERK activation could not be definitely concluded and needs further studies.
IEC-Specific CD98 Overexpression Enhances Intestinal Tumorigenesis in Apc
Min/ þ Mice by Increasing Expression of Proinflammatory Cytokines and Chemokines We further investigated the role shown by CD98 in intestinal tumorigenesis by analyzing the expression levels of proinflammatory cytokines and chemokines that can promote tumor development. 27 Significant increases in the levels of mRNA encoding proinflammatory cytokines (TNF-a, IL-1b, and IL-6) and keratinocyte-derived chemokine (KC) were found in Tg/Apc Min/ þ mice compared with Apc Min/ þ animals ( Figure 6 ). Overall, the results showed that IEC-specific CD98 overexpression enhances intestinal tumorigenesis in Apc Min/ þ mice by increasing the expression levels of positive regulators of tumorigenesis. 
IEC-Specific CD98 Downregulation Decreases Intestinal

CD98 modulates tumorigenesis in Apc
Min/ þ mice HTT Nguyen et al which we recently generated. 8 Compared with CD98 f/ þ / Apc Min/ þ mice, CD98 f/ þ VC/Apc Min/ þ animals developed a significantly decreased number of intestinal adenomas, as determined at 16-18 weeks of age (Figure 7a) . Interestingly, only 42% of CD98 f/ þ VC/Apc Min/ þ mice (5/12 animals) developed tumors in the colon compared with 83% of CD98 f/ þ /Apc Min/ þ mice (10/12 animals; Figure 7b ). Analysis of total adenomas size (mm) developed in each mouse showed a significant decrease in (Figure 7c) , with more smaller tumors observed (Figure 7d) .
As expected, compared with CD98
Min/ þ animals exhibited attenuated intestinal epithelial proliferation as shown by decreases in the numbers Min/ þ mice independently of the action of the Wnt-APCb-catenin pathway. In addition, the levels of mRNA encoding the cytokines/chemokines TNF-a, IL-1b IL-6, and KC were (Figure 7h) . Overall, the results showed that IEC-specific CD98 downregulation suppresses intestinal tumorigenesis in Apc Min/ þ mice by inhibiting expression of positive regulators of tumorigenesis.
DISCUSSION
It is widely recognized that overt inflammation can promote neoplasia. 28, 29 Recently, we generated gain-and loss-offunction mouse models featuring genetic manipulation of CD98 expression specifically in IECs, and showed that CD98 has a critical role in the regulation of intestinal homeostasis, inflammation, and inflammation-associated tumorigenesis. In the present study, we show that IEC-specific CD98 expression critically regulates intestinal tumorigenesis in the Apc
Min/ þ mouse model. 
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We recently assessed the role shown by intestinal CD98 in inflammation-induced tumorigenesis using a mouse model of colitis-associated cancer. 8 We found that IEC-specific CD98 overexpression promoted colitis-associated tumorigenesis by stimulating cell proliferation and production of proinflammatory mediators. 8 In the present study, we show that CD98 expression is upregulated in the intestinal adenomas of Apc Min/ þ mice, which spontaneously develop colon cancer because of the presence of a germ-line mutation in the tumor suppressor APC gene. In addition, CD98 overexpression in IECs increased both tumor incidence and size in Apc Min/ þ mice. It is worthy to note that Tg mice did not develop spontaneously intestinal adenomas. We further show that the effect of CD98 overexpression on intestinal tumorigenesis in Apc Min/ þ mice could be explained by the fact that CD98 regulates cell proliferation and survival. Indeed, it has been shown that CD98 controls integrin signaling, which regulates cell proliferation, survival, migration, and epithelial adhesion/polarity, [1] [2] [3] and has crucial roles in intestinal homeostasis and tumorigenesis in mice. 8 In the present work, we observed that IEC-specific CD98 overexpression increased cell proliferation and reduced apoptosis in Apc Min/ þ mice, with both of these effects contributed to intestinal tumorigenesis. We speculate that CD98 overexpression affects integrin signaling, which is accompanied by enhanced cell proliferation and survival; these are important aspects of the tumorigenic activity associated with IEC-specific CD98 overexpression in Apc Min/ þ mice. Accumulation of b-catenin in nuclei, via formation of the b-catenin/TCF complexes, activates various downstream targets including c-myc and cyclin D1. Herein, we show that IEC-specific CD98 overexpression increases tumorigenesis in Apc Min/ þ mice in a manner independent of the action of the Wnt-APC-b-catenin pathway. It is known that activation of MEK-ERK pathway phosphorylate c-myc, thereby stabilizing c-myc by preventing ubiquitination and proteasomal degradation. [23] [24] [25] It has also recently been shown that MyD88-dependent ERK activation increases the level of c-myc protein and drives intestinal tumorigenesis in Apc Min/ þ mice. Therefore, our data suggest that CD98 overexpression increases synthesis of oncogenic c-myc via activation of ERK, although further studies on the role of ERK signaling pathway in CD98 effect on tumorigenesis in Apc Min/ þ mice are needed to make a definite conclusion. Another important finding of the present study is that production of proinflammatory cytokines and chemokines that critically contributes to tumor progression 29 was enhanced in Apc Min/ þ mice with IEC-specific CD98 overexpression (Apc Min/ þ /Tg). These data are consistent with our previous finding that IEC-specific CD98 overexpression enhanced colonic tumor incidence and growth by stimulating inflammation-induced production of proinflammatory cytokines/chemokines, including the critical regulators IL-6 and TNF-a. However, we can not exclude the possibility that the elevated proinflammatory cytokine/chemokine production could be a consequence of the increase in tumorigenesis in Apc Min/ þ /Tg mice. Employing the IEC-specific CD98 loss-of-function mouse model that we generated recently, 8 we validated the role of intestinal CD98 in modulating intestinal tumor development in Apc Min/ þ mice. IEC-specific CD98 downregulation efficiently attenuated both tumor incidence and growth in such mice. The reducing effect on tumor incidence and tumor size during CAC development of IEC-specific CD98 downregulation was given by its capability to attenuate inflammation-associated cytokine/chemokine production and IEC proliferation, which is consistent with the mechanism underlying tumorigenic activity of IEC-specific CD98 overexpression.
In summary, our current findings, together with those of our previous study on the role shown by intestinal CD98 in regulation of intestinal homeostasis and inflammation-associated tumorigenesis, 8 suggest that CD98 is an attractive target for the development of novel therapeutic drugs for prevention and treatment of CRC.
